Showing results (981-990 of 1,020) with videos related to

Sort By:
Pageof 102
Cancer Research Communications|April 19, 2026
Dietary Fat Content Influences PanIN Progression and Pancreatic Cancer Development in MiceUrvinder Kaur Sardarni, Erika Y Faraoni, Alyssa M Waller, et al.
Cancer Research Communications|April 21, 2026
Advanced CD276-Targeting Dual-Payload Antibody-Drug Conjugates for Cancer TherapyZhuoxin Zhou, Davis Ballard, Jiashuai Zhang, et al.
Cancer Research Communications|April 6, 2026
Metastasis-Associated Wound Repair Promotes Reciprocal Lung Epithelium Activation and Breast Cancer Metastatic OutgrowthJessica L Christenson, Nicole S Spoelstra, Michelle M Williams, et al.
Cancer Research Communications|April 20, 2026
Integrated single-cell whole genome sequencing and spatial transcriptomics reveal intra-tumoral heterogeneity in ovarian cancerRania Bassiouni, Yuxin Jin, Lee D Gibbs, et al.
Cancer Research Communications|April 22, 2026
Clinical and Molecular Characterization of a Rare EGFR cis Compound L833V/H835L Mutation in Non-Small Cell Lung CancerYo Han Jeon, Ahjin Lim, Myung Kyung Choi, et al.
Cancer Research Communications|June 10, 2026
Peptide-reactive T cell response as a novel biomarker in head and neck cancer patients treated with anti-PD-1 antibodyTakumi Kumai, Shota Sakaue, Hisataka Ominato, et al.
Cancer Research Communications|June 11, 2026
Clinical evaluation of ex vivo expanded MUC1-specific peripheral blood T Cells for adoptive immunotherapy in relapsed/refractory multiple myelomaErin W Meermeier, Dara S Missan, Latha B Pathangey, et al.
Cancer Research Communications|June 30, 2026
Comprehensive Profiling of Cell Surface Proteins in Testicular Germ Cell TumorsHedyeh Ebrahimi, Ali Moradi, Regina Barragan-Carrillo, et al.
Cancer Research Communications|July 2, 2026
Clinical validation of tissue and liquid companion diagnostics for BRAF V600E detection in non-small cell lung cancers from the PHAROS studyGregory J Riely, Jean-François Martini, Norberto Pantoja Galicia, et al.
Cancer Research Communications|June 26, 2026
A phase 1b study of chemo-immunotherapy with pegylated liposomal doxorubicin and Pembrolizumab in estrogen receptor positive metastatic breast cancerAlberto A Gabizon, Hadar Goldvaser, Adar Yaacov, et al.
Pageof 102